180 related articles for article (PubMed ID: 14594332)
1. Prevalence and patterns of use of psychoactive medicines among individuals with autism in the Autism Society of Ohio.
Aman MG; Lam KS; Collier-Crespin A
J Autism Dev Disord; 2003 Oct; 33(5):527-34. PubMed ID: 14594332
[TBL] [Abstract][Full Text] [Related]
2. Prevalence and patterns of use of psychoactive medicines in individuals with autism in the Autism Society of North Carolina.
Langworthy-Lam KS; Aman MG; Van Bourgondien ME
J Child Adolesc Psychopharmacol; 2002; 12(4):311-21. PubMed ID: 12625991
[TBL] [Abstract][Full Text] [Related]
3. Medication patterns in patients with autism: temporal, regional, and demographic influences.
Aman MG; Lam KS; Van Bourgondien ME
J Child Adolesc Psychopharmacol; 2005 Feb; 15(1):116-26. PubMed ID: 15741793
[TBL] [Abstract][Full Text] [Related]
4. Psychotropic and anticonvulsant drugs in subjects with autism: prevalence and patterns of use.
Aman MG; Van Bourgondien ME; Wolford PL; Sarphare G
J Am Acad Child Adolesc Psychiatry; 1995 Dec; 34(12):1672-81. PubMed ID: 8543539
[TBL] [Abstract][Full Text] [Related]
5. Medication use among children with autism spectrum disorders.
Oswald DP; Sonenklar NA
J Child Adolesc Psychopharmacol; 2007 Jun; 17(3):348-55. PubMed ID: 17630868
[TBL] [Abstract][Full Text] [Related]
6. Treatment incidence and patterns in children and adolescents with autism spectrum disorders.
Witwer A; Lecavalier L
J Child Adolesc Psychopharmacol; 2005 Aug; 15(4):671-81. PubMed ID: 16190798
[TBL] [Abstract][Full Text] [Related]
7. AEDs and psychotropic drugs in children with autism and epilepsy.
Tuchman R
Ment Retard Dev Disabil Res Rev; 2004; 10(2):135-8. PubMed ID: 15362171
[TBL] [Abstract][Full Text] [Related]
8. Psychotropic medication use among children with autism spectrum disorders enrolled in a national registry, 2007-2008.
Rosenberg RE; Mandell DS; Farmer JE; Law JK; Marvin AR; Law PA
J Autism Dev Disord; 2010 Mar; 40(3):342-51. PubMed ID: 19806445
[TBL] [Abstract][Full Text] [Related]
9. Use and cost of psychotropic drugs among recipients with autism in a state Medicaid fee-for-service programme.
Khanna R; Jariwala K; West-Strum D
J Intellect Disabil Res; 2013 Feb; 57(2):161-71. PubMed ID: 22471524
[TBL] [Abstract][Full Text] [Related]
10. Psychotropic medication use among Medicaid-enrolled children with autism spectrum disorders.
Mandell DS; Morales KH; Marcus SC; Stahmer AC; Doshi J; Polsky DE
Pediatrics; 2008 Mar; 121(3):e441-8. PubMed ID: 18310165
[TBL] [Abstract][Full Text] [Related]
11. Side effects associated with psychoactive medication in individuals with autism.
Aman MG; Van Bourgondien ME; Osborne PW; Sarphare G
J Autism Dev Disord; 1997 Jun; 27(3):342-4. PubMed ID: 9229265
[No Abstract] [Full Text] [Related]
12. Prescription Trends of Psychotropics in Children and Adolescents with Autism Based on Nationwide Health Insurance Data.
Hong M; Lee SY; Han J; Park JC; Lee YJ; Hwangbo R; Chang H; Cho SW; Bhang SY; Kim B; Hwang JW; Bahn GH
J Korean Med Sci; 2017 Oct; 32(10):1687-1693. PubMed ID: 28875615
[TBL] [Abstract][Full Text] [Related]
13. A longitudinal investigation of psychotropic and non-psychotropic medication use among adolescents and adults with autism spectrum disorders.
Esbensen AJ; Greenberg JS; Seltzer MM; Aman MG
J Autism Dev Disord; 2009 Sep; 39(9):1339-49. PubMed ID: 19434487
[TBL] [Abstract][Full Text] [Related]
14. [Review of psychopharmacological treatments in adolescents and adults with autistic disorders].
Baghdadli A; Gonnier V; Aussilloux C
Encephale; 2002; 28(3 Pt 1):248-54. PubMed ID: 12091786
[TBL] [Abstract][Full Text] [Related]
15. Psychopharmacological treatment in children and adolescents with autism spectrum disorders in Germany.
Bachmann CJ; Manthey T; Kamp-Becker I; Glaeske G; Hoffmann F
Res Dev Disabil; 2013 Sep; 34(9):2551-63. PubMed ID: 23747941
[TBL] [Abstract][Full Text] [Related]
16. Concomitant medication use in children with autism spectrum disorder: Data from the Autism Biomarkers Consortium for Clinical Trials.
Shurtz L; Schwartz C; DiStefano C; McPartland JC; Levin AR; Dawson G; Kleinhans NM; Faja S; Webb SJ; Shic F; Naples AJ; Seow H; Bernier RA; Chawarska K; Sugar CA; Dziura J; Senturk D; Santhosh M; Jeste SS
Autism; 2023 May; 27(4):952-966. PubMed ID: 36086805
[TBL] [Abstract][Full Text] [Related]
17. Drug-refractory aggression, self-injurious behavior, and severe tantrums in autism spectrum disorders: a chart review study.
Adler BA; Wink LK; Early M; Shaffer R; Minshawi N; McDougle CJ; Erickson CA
Autism; 2015 Jan; 19(1):102-6. PubMed ID: 24571823
[TBL] [Abstract][Full Text] [Related]
18. Psychiatric comorbidities and use of psychotropic medications in people with autism spectrum disorder in the United States.
Houghton R; Ong RC; Bolognani F
Autism Res; 2017 Dec; 10(12):2037-2047. PubMed ID: 28963809
[TBL] [Abstract][Full Text] [Related]
19. Should clinical trial research of psychotropic medication in autism control for gastrointestinal symptoms?
Heitzer AM; Job MA; Pandit NK; Valdovinos MG
J Clin Pharmacol; 2014 Oct; 54(10):1093-6. PubMed ID: 24788353
[TBL] [Abstract][Full Text] [Related]
20. Use of psychotropic drugs in patients with autism spectrum disorders: a systematic review.
Jobski K; Höfer J; Hoffmann F; Bachmann C
Acta Psychiatr Scand; 2017 Jan; 135(1):8-28. PubMed ID: 27624381
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
